601607 上海医药
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资6,895,331-14.52%8,066,8458,351,9109,232,6449,073,275
投资性房地产422,06915.32%366,010314,673246,415213,323
固定资产14,951,1350.27%14,911,04512,155,05511,539,28910,484,118
在建工程2,382,16310.87%2,148,6523,569,6292,777,3632,914,130
无形资产9,164,48563.14%5,617,4626,050,8366,244,1406,049,431
商誉12,836,41815.17%11,145,58611,393,33211,335,92711,238,972
其他非流动资产6,958,701-2.41%7,130,7227,703,2367,246,2536,967,826
53,610,3028.55%49,386,32349,538,67148,622,03146,941,077

流动资产
货币资金39,094,7859.37%35,744,32830,517,70627,401,39622,390,386
应收账款86,377,8459.16%79,129,20672,933,88166,759,85458,107,770
存货40,899,0775.02%38,943,67036,623,39434,460,21727,104,035
其他流动资产18,085,0460.44%18,005,90422,358,88120,891,4048,892,241
184,456,7547.35%171,823,107162,433,862149,512,871116,494,432

流动负债
短期借款45,621,71819.85%38,064,09935,560,50027,750,58922,514,574
应付票据7,112,114-23.04%9,241,1336,717,4445,961,7244,764,748
应付帐款55,899,52211.26%50,241,78747,915,01145,603,80537,230,666
其他流动负债31,497,66810.55%28,491,36732,178,92531,374,92827,314,335
140,131,02211.18%126,038,386122,371,879110,691,04691,824,324
流动资产净值44,325,732-3.19%45,784,72140,061,98338,821,82524,670,109
资产总额减流动负债97,936,0342.91%95,171,04489,600,65587,443,85571,611,186

非流动负债
长期借款4,698,142-43.61%8,331,3345,786,1556,259,7997,157,752
应付债券0--0000
其他非流动负债4,379,98841.41%3,097,3463,488,4073,181,6055,387,224
9,078,129-20.57%11,428,6809,274,5629,441,40412,544,975

总权益
    实收股本3,708,3620.01%3,707,9723,703,3013,697,5462,842,089
    储备项目71,387,2915.03%67,967,64864,820,84263,365,46046,517,391
股东权益75,095,6534.77%71,675,62068,524,14367,063,00649,359,480
非控股权益13,762,25214.05%12,066,74411,801,95010,939,4459,706,730